ETON Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 mai 2024 @ 22:00):

Stats
Dagens volum	25 959.00
Gjennomsnittsvolum	63 919.00
Markedsverdi	93.00M
EPS	$0 ( 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-90.50
ATR14	$0.0120 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Gruber James R.	Buy	144 677	Stock Option (Right to buy)
2024-02-13	Adams Jennifer Mckie	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Brynjelsen Sean	Buy	438 633	Stock Option (Right to buy)
2024-02-13	Casamento Charles J	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Krempa David	Buy	144 677	Stock Option (Right to buy)

INSIDER POWER
56.09
Last 96 transactions
Buy: 4 266 352 \| Sell: 3 981 653

Volum Korrelasjon

Lang: 0.18 (neutral)

Kort: -0.82 (strong negative)

Signal:(47.184) Neutral

Eton Pharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
CPSH	0.917
AZ	0.91
ASPS	0.897
NLSP	0.892
RGC	0.89
TTEC	0.888
NDLS	0.887
CLEU	0.886
PRTS	0.886
CASI	0.886

10 Mest negative korrelasjoner
DXPE	-0.916
MNMD	-0.905
BNR	-0.904
CTHR	-0.904
CDXC	-0.9
STAA	-0.898
SWBI	-0.897
WHLR	-0.897
KNTK	-0.889
RGLS	-0.889

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Eton Pharmaceuticals Inc Korrelasjon - Valuta/Råvare

-0.12
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.52
( weak negative )

Eton Pharmaceuticals Inc Økonomi

Annual	2023
Omsetning:	$31.64M
Bruttogevinst:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2023
Omsetning:	$31.64M
Bruttogevinst:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2022
Omsetning:	$21.25M
Bruttogevinst:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2021
Omsetning:	$21.83M
Bruttogevinst:	$19.21M (87.99 %)
EPS:	$-0.0800

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.